84 related articles for article (PubMed ID: 12023746)
21. Comparison of twice-daily and three-times-daily dosing of dorzolamide in ocular hypertension and primary open-angle glaucoma patients treated with latanoprost.
Lupinacci AP; Netland PA; Fung KH; Evans D; Zhao Y
Adv Ther; 2008 Mar; 25(3):231-9. PubMed ID: 18369537
[TBL] [Abstract][Full Text] [Related]
22. Long-term effects of latanoprost monotherapy on intraocular pressure in Japanese glaucoma patients.
Kashiwagi K; Tsumura T; Tsukahara S
J Glaucoma; 2008 Dec; 17(8):662-6. PubMed ID: 19092463
[TBL] [Abstract][Full Text] [Related]
23. Latanoprost in pediatric glaucoma--pediatric exposure over a decade.
Black AC; Jones S; Yanovitch TL; Enyedi LB; Stinnett SS; Freedman SF
J AAPOS; 2009 Dec; 13(6):558-62. PubMed ID: 20006816
[TBL] [Abstract][Full Text] [Related]
24. A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.
Choplin N; Bernstein P; Batoosingh AL; Whitcup SM;
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S19-25. PubMed ID: 15016558
[TBL] [Abstract][Full Text] [Related]
25. The effect of latanoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma.
Oh JY; Park KH
Korean J Ophthalmol; 2005 Dec; 19(4):297-301. PubMed ID: 16491821
[TBL] [Abstract][Full Text] [Related]
26. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma.
Nagar M; Ogunyomade A; O'Brart DP; Howes F; Marshall J
Br J Ophthalmol; 2005 Nov; 89(11):1413-7. PubMed ID: 16234442
[TBL] [Abstract][Full Text] [Related]
27. Intraocular pressure-lowering efficacy of latanoprost in patients with normal-tension glaucoma or primary open-angle glaucoma.
Tamada Y; Taniguchi T; Murase H; Yamamoto T; Kitazawa Y
J Ocul Pharmacol Ther; 2001 Feb; 17(1):19-25. PubMed ID: 11322634
[TBL] [Abstract][Full Text] [Related]
28. Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma.
Konstas AG; Mylopoulos N; Karabatsas CH; Kozobolis VP; Diafas S; Papapanos P; Georgiadis N; Stewart WC
Eye (Lond); 2004 Sep; 18(9):893-9. PubMed ID: 15002024
[TBL] [Abstract][Full Text] [Related]
29. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
Bucci MG
J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
[TBL] [Abstract][Full Text] [Related]
30. Using diurnal intraocular pressure fluctuation to assess the efficacy of fixed-combination latanoprost/timolol versus latanoprost or timolol monotherapy.
Varma R; Hwang LJ; Grunden JW; Bean GW
Br J Ophthalmol; 2010 Jan; 94(1):80-4. PubMed ID: 19692375
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the additive effects of nipradilol and carteolol to latanoprost in open-angle glaucoma.
Haneda M; Shirato S; Maruyama K; Ohno Y
Jpn J Ophthalmol; 2006; 50(1):33-7. PubMed ID: 16453185
[TBL] [Abstract][Full Text] [Related]
32. Effect of concomitant use of latanoprost and brinzolamide on 24-hour variation of IOP in normal-tension glaucoma.
Nakamoto K; Yasuda N
J Glaucoma; 2007; 16(4):352-7. PubMed ID: 17570997
[TBL] [Abstract][Full Text] [Related]
33. Effect of latanoprost as adjunctive therapy.
DesMarchais B; Candal E; Weitzman M; Shields MB
Can J Ophthalmol; 2000 Jun; 35(4):214-7. PubMed ID: 10900518
[TBL] [Abstract][Full Text] [Related]
34. Impact of age, diagnosis, and history of glaucoma surgery on outcomes in pediatric patients treated with latanoprost.
Maeda-Chubachi T; Chi-Burris K; Simons B; Brémond-Gignac D; Freedman S; Khaw PT; Wirostko B; Yan E;
J Glaucoma; 2013; 22(8):614-9. PubMed ID: 23524858
[TBL] [Abstract][Full Text] [Related]
35. Relation between axial length of the eye and hypotensive effect of latanoprost in primary open angle glaucoma.
Arranz-Marquez E; Teus MA
Br J Ophthalmol; 2004 May; 88(5):635-7. PubMed ID: 15090414
[TBL] [Abstract][Full Text] [Related]
36. Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range.
Varma R; Hwang LJ; Grunden JW; Bean GW; Sultan MB
Am J Ophthalmol; 2009 Aug; 148(2):221-6. PubMed ID: 19427617
[TBL] [Abstract][Full Text] [Related]
37. A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
Facio AC; Reis AS; Vidal KS; de Moraes CG; Suzuki R; Hatanaka M; Susanna R
J Ocul Pharmacol Ther; 2009 Oct; 25(5):447-51. PubMed ID: 19860553
[TBL] [Abstract][Full Text] [Related]
38. [Five years retrospective study of latanoprost glaucoma treatment].
Závorková M; Susický P
Cesk Slov Oftalmol; 2007 Jul; 63(4):292-8. PubMed ID: 17682609
[TBL] [Abstract][Full Text] [Related]
39. Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes.
Thomas R; Parikh R; Muliyil J; George R; Paul P; Abraham LM
Indian J Ophthalmol; 2003 Jun; 51(2):123-8. PubMed ID: 12831141
[TBL] [Abstract][Full Text] [Related]
40. Effect of previous argon laser trabeculoplasty on the ocular hypotensive action of latanoprost.
Arranz-Marquez E; Teus MA
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1073-6. PubMed ID: 16416130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
